Literature DB >> 29876632

[What rheumatologists can learn from nephrologists].

V Schwenger1.   

Abstract

Rheumatology and nephrology have some characteristics in common. In some places this leads to the marginalization of the respective other discipline, instead of an interdisciplinary morbidity-oriented approach. In order to cope with the complexity of systemic autoimmune diseases, a care mandate should be defined and interdisciplinary and cross-sectoral structures, such as interdisciplinary boards or special outpatient clinics should be established.

Entities:  

Keywords:  Autoimmune systemic diseases; Healthcare services; Interdisciplinary treatment approach; Multisectoral care; Special outpatient services

Mesh：

Year:  2018        PMID： 29876632     DOI： 10.1007/s00393-018-0486-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  39 in total

1.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  High salt reduces the activation of IL-4- and IL-13-stimulated macrophages.

Authors:  Katrina J Binger; Matthias Gebhardt; Matthias Heinig; Carola Rintisch; Agnes Schroeder; Wolfgang Neuhofer; Karl Hilgers; Arndt Manzel; Christian Schwartz; Markus Kleinewietfeld; Jakob Voelkl; Valentin Schatz; Ralf A Linker; Florian Lang; David Voehringer; Mark D Wright; Norbert Hubner; Ralf Dechend; Jonathan Jantsch; Jens Titze; Dominik N Müller
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

3.  Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.

Authors:  Bhupesh Panwar; Suzanne E Judd; Virginia G Wadley; Nancy S Jenny; Virginia J Howard; Monika M Safford; Orlando M Gutiérrez
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

4.  T cell activation in rheumatoid synovium is B cell dependent.

Authors:  S Takemura; P A Klimiuk; A Braun; J J Goronzy; C M Weyand
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

Authors:  Lorraine Harper; Matthew D Morgan; Michael Walsh; Peter Hoglund; Kerstin Westman; Oliver Flossmann; Vladimir Tesar; Phillipe Vanhille; Kirsten de Groot; Raashid Luqmani; Luis Felipe Flores-Suarez; Richard Watts; Charles Pusey; Annette Bruchfeld; Niels Rasmussen; Daniel Blockmans; Caroline O Savage; David Jayne
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

6.  Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

Authors:  Mary Anne Dooley; David Jayne; Ellen M Ginzler; David Isenberg; Nancy J Olsen; David Wofsy; Frank Eitner; Gerald B Appel; Gabriel Contreras; Laura Lisk; Neil Solomons
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

7.  Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Authors:  Loïc Guillevin; Christian Pagnoux; Alexandre Karras; Chahera Khouatra; Olivier Aumaître; Pascal Cohen; François Maurier; Olivier Decaux; Jacques Ninet; Pierre Gobert; Thomas Quémeneur; Claire Blanchard-Delaunay; Pascal Godmer; Xavier Puéchal; Pierre-Louis Carron; Pierre-Yves Hatron; Nicolas Limal; Mohamed Hamidou; Maize Ducret; Eric Daugas; Thomas Papo; Bernard Bonnotte; Alfred Mahr; Philippe Ravaud; Luc Mouthon
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

8.  Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.

Authors:  C C Najafi; S M Korbet; E J Lewis; M M Schwartz; M Reichlin; J Evans
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

9.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

10.  Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Authors:  Frédéric A Houssiau; David D'Cruz; Shirish Sangle; Philippe Remy; Carlos Vasconcelos; Radmila Petrovic; Christoph Fiehn; Enrique de Ramon Garrido; Inge-Magrethe Gilboe; Maria Tektonidou; Daniel Blockmans; Isabelle Ravelingien; Véronique le Guern; Geneviève Depresseux; Loïc Guillevin; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2010-09-10       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.